Associated Papers
Targeting PCSK9 to tackle cardiovascular disease.
Hummelgaard S et al.
Pharmacology & Therapeutics, 2023
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.
Zhou Y et al.
Journal of Lipid Research, 2018
30076208 (PubMed )
Supplement: 10.1194_P086710_jlr.P086710-4.xlsx › APOE
Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B.
Toniutto P et al.
Journal of Medical Virology, 2010
Select a paper to view details